Seattle Children's Hospital

This early-stage study is testing a new type of personalized immune cell therapy for children and young adults with a specific type of leukemia that has come back or hasn't responded to other treatments. Doctors take a patient's own immune cells (T-cells), modify them in a lab to…

This study is testing a new support program called the Family Bridge Program. It aims to help low-income families from diverse backgrounds better navigate the hospital system and communicate with their child's medical team. A trained guide provides practical help, communication c…

This early-stage study is testing a new treatment for children and young adults whose brain or spinal cord tumors have come back or haven't responded to standard therapies. Doctors collect the patient's own immune cells, modify them in a lab to recognize and attack cancer cells, …

This early-stage study is testing a new two-part treatment for osteosarcoma that has come back or not responded to standard therapies. Doctors take a patient's own immune cells (T cells), modify them in a lab to recognize a special marker, and then infuse them back. A second drug…

This study is testing whether adding a weekly medication to family-based behavioral therapy helps children aged 10-12 manage obesity better. Researchers will use brain scans to understand how children's brains respond to food cues and whether this affects weight loss. The goal is…

This early-stage study is testing a new type of personalized cell therapy for children and young adults whose solid tumors have come back or haven't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cance…

This study is testing a new cell therapy for children and young adults (up to age 30) whose leukemia or lymphoma has returned or not responded to other treatments. Doctors take a patient's own immune cells (T-cells), modify them in a lab to recognize a protein called CD22 on canc…

This early-stage study is testing a new type of personalized immune cell therapy called SC-CAR4BRAIN for children and young adults with aggressive brain tumors that have come back or not responded to standard treatments. Doctors collect a patient's own immune cells, modify them i…

This early-phase study is testing the safety and feasibility of a new treatment called CAR T-cell therapy for children and young adults whose solid tumors have come back or not responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to be…

This study is testing two practical methods to help doctors communicate better with patients who don't speak English well. Researchers are comparing mobile video interpreters (like a video call with a translator) against online training modules for doctors. They're measuring whet…